A detailed history of One Ascent Financial Services LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, One Ascent Financial Services LLC holds 8,855 shares of BMY stock, worth $507,657. This represents 0.33% of its overall portfolio holdings.

Number of Shares
8,855
Holding current value
$507,657
% of portfolio
0.33%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $351,189 - $458,246
8,855 New
8,855 $458,000
Q1 2024

Apr 16, 2024

SELL
$47.98 - $54.4 $15,401 - $17,462
-321 Reduced 3.22%
9,653 $523,000
Q4 2023

Jan 11, 2024

BUY
$48.48 - $57.85 $483,539 - $576,995
9,974 New
9,974 $512,000
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $92,191 - $104,565
-1,403 Reduced 25.27%
4,150 $288,000
Q4 2022

Jan 12, 2023

SELL
$68.48 - $81.09 $101,350 - $120,013
-1,480 Reduced 21.04%
5,553 $400,000
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $40 - $23,743
-309 Reduced 4.21%
7,033 $500,000
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $291,424 - $320,959
4,013 Added 120.55%
7,342 $565,000
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $7,500 - $8,993
-122 Reduced 3.54%
3,329 $243,000
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $185,077 - $215,756
3,451 New
3,451 $215,000
Q4 2020

Jan 13, 2021

SELL
$57.74 - $65.43 $547,721 - $620,668
-9,486 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$57.43 - $63.64 $57,717 - $63,958
1,005 Added 11.85%
9,486 $572,000
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $22,037 - $25,764
402 Added 4.98%
8,481 $499,000
Q1 2020

Apr 14, 2020

SELL
$46.4 - $67.43 $297,609 - $432,496
-6,414 Reduced 44.26%
8,079 $450,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $713,200 - $930,305
14,493 New
14,493 $930,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.